An effective protocol for pharmacological defatting of primary human hepatocytes which is non-toxic to cholangiocytes or intrahepatic endothelial cells.

For cholangiocytes the supplementation of the media with those drugs improved cellular viability in 25% although the difference did not reach statistical significance (125% [75–166%] vs. 100% [57–116], p = 0.413).

also in 111,027 other papers